Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gemavip is an Italian life sciences company based in Sardinia that specializes in phytotherapy and ozone therapy products for consumer health and professional medical use. Founded in 2007, the company leverages the therapeutic properties of ozonated organic extra virgin olive oil to create natural health solutions for oral hygiene, vascular health, and dermatology. Its primary product lines include Ialozon, a range of oral care products serving as non-chemical alternatives to chlorhexidine, and Vitgase, which focuses on microcirculation support and inflammatory conditions. Gemavip operates an extensive distribution network across Italy and is expanding internationally into Europe and the Middle East. The company maintains research collaborations with several Italian universities to clinically validate its natural formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gemavip.